EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Mar. 15, 2018--
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in
vitro diagnostic technologies to the healthcare industry, today
announced that Gary Maharaj, president and chief executive officer, and
Andy LaFrence, vice president of finance and information systems and
chief financial officer, will be attending two upcoming investor
conferences in New York City.
On Tuesday, March 20, at 1:35 p.m. ET (12:35 p.m. CT), company
management will make a presentation at the Oppenheimer 28th Annual
On Tuesday, March 27, at 2:30 p.m. ET (1:30 p.m. CT), company management
will make a presentation at the Needham Healthcare Conference.
Live audio webcasts of the presentations can be accessed by going to the
investor relations portion of the Company’s website at www.surmodics.com
and clicking on the webcast icon. Webcasts will be archived on the
Company’s website for 90 days.
About Surmodics, Inc.
Surmodics is the global leader in
surface modification technologies for intravascular medical devices and
a leading provider of chemical components for in vitro diagnostic
(IVD) immunoassay tests and microarrays. Surmodics is pursuing highly
differentiated whole-product solutions that are designed to address
unmet clinical needs for its medical device customers and engineered to
the most demanding requirements. This key growth strategy leverages the
combination of the Company’s expertise in proprietary surface
technologies, along with enhanced device design, development and
manufacturing capabilities. The Company mission remains to improve the
detection and treatment of disease. Surmodics is headquartered in Eden
Prairie, Minnesota. For more information, visit www.surmodics.com. The
content of Surmodics’ website is not part of this press release or part
of any filings that the company makes with the SEC.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180315005284/en/
Source: Surmodics, Inc.
Andy LaFrence, 952-500-7000